Intravenous Immunoglobulin (IVIg) for unexplained infertility: a case series

被引：0
|
作者：
Genest, G. [1 ]
Elliott, B. [2 ]
Spitzer, K. [3 ]
Laskin, C. A. [4 ]
Buckett, W. [5 ]
Lapensee, L. [6 ,7 ]
Kadoch, I. J. [6 ,7 ]
Gold, P. [1 ]
机构：
[1] McGill Univ, Montreal Gen Hosp, Dept Immunol, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] Trio Fertil, Toronto, ON, Canada
[4] Univ Toronto, Dept Med & Obstet, Toronto, ON, Canada
[5] McGill Univ, Reprod Ctr, Montreal, PQ, Canada
[6] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada
[7] Ovo Clin, Dept Reprod Med, Montreal, PQ, Canada
来源：
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY | 2018年 / 45卷 / 05期
关键词：
Immunology; Infertility; Maternal-fetal medicine; PREGNANCY;
D O I：
10.12891/ceog4566.2018
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Intravenous Immunoglobulin (IVIg) is a potential treatment for immune mediated reproductive failure (IMRF), but its role in infertility treatments remains controversial. There is evidence that administering IVIg before conception improves pregnancy outcomes. In the present cohort, 13/15 (86%) patients had a live birth after receiving pre-conceptual Wig at immunomodulatory doses. No serious maternal or fetal side effects directly attributable to IVIg were reported. The present results support the need for a randomized controlled trial (RCT) with this protocol.
引用
收藏
页码：699 / 701
页数：3
相关论文
共 50 条
  • [21] INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN THE PREVENTION OF IMPLANTATION FAILURES
    DEPLACIDO, G
    ZULLO, F
    MOLLO, A
    CAPPIELLO, F
    NAZZARO, A
    COLACURCI, N
    PALUMBO, G
    HUMAN ENDOMETRIUM, 1994, 734 : 232 - 234
  • [22] Intravenous immunoglobulin (IVIg) for the treatment of Alzheimer disease
    Relkin, Norman
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S55 - S55
  • [23] INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY OF NEONATAL SEPSIS
    WEISMAN, LE
    STOLL, B
    KUESER, T
    RUBIO, T
    FRANK, G
    HEIMAN, H
    SUBRAMANIAN, S
    HANKINS, C
    HEMMING, V
    FISCHER, GW
    PEDIATRIC RESEARCH, 1990, 27 (04) : A277 - A277
  • [24] Basic principles of intravenous immunoglobulin (IVIg) treatment
    Stangel, Martin
    Pul, Refik
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 5) : 18 - 24
  • [25] Intravenous immunoglobulin (IVIG) for the treatment of antiphospholipid syndrome
    Heilmann, L
    Berg, C
    von Tempelhoff, GF
    Gehler, J
    Zimmer, B
    Wolf, H
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 1998, 202 (04): : 164 - 167
  • [26] Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)
    Kaveri, S
    Prasad, N
    Vassilev, T
    Hurez, V
    Pashov, A
    LacroixDesmazes, S
    Kazatchkine, M
    MULTIPLE SCLEROSIS, 1997, 3 (02): : 121 - 128
  • [27] USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) THERAPY IN ADULTS
    HERROD, HG
    ALLERGY PROCEEDINGS, 1994, 15 (06): : 309 - 312
  • [28] Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia
    Geriak, Matthew
    McGrosso, Dominic
    Gonzalez, David J.
    Dehner, Matthew
    Sakoulas, George
    AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
  • [29] Factor XI is a contaminant in intravenous immunoglobulin (IVIG) preparations
    Kon, RH
    Wolberg, AS
    Oliver, JA
    Monroe, DM
    Hoffman, M
    THROMBOSIS AND HAEMOSTASIS, 1999, : 459 - 460
  • [30] A Case Series of Intravenous Immunoglobulin-Associated Hemolysis
    Watanaboonyongcharoen, P.
    Onspuns, S.
    Ritteeverakul, P.
    Kongsangbut, P.
    Rojnuckarin, P.
    TRANSFUSION, 2016, 56 : 49A - 50A
12345